Viral IL-10 gene therapy inhibits TNF-α and IL-1β, not IL-6, in the newborn endotoxemic mouse

Journal of Pediatric Surgery

Volumn 31, Issue 3, 1996, Pages 411-414

  Drazan, Kenneth E ^a,b,c   Wu, Lily ^a,b   Bullington, Deborah ^a,b   Shaked, Abraham ^a,b  

^a UCLA School of Medicine ^*

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; GENE THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; MODULATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

EID: 0029980286     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(96)90749-6     Document Type: Article

References (21)

1. Gan XH, Robin JP, Huerta JM, et al: Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative. J Clin Immunol 14:280-288, 1994
2. Suzuki S, Toledo-Pereyra LH: Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. J Surg Res 57:253-258, 1994
3. Morecroft JA, Spitz L, Hamilton PA, et al: Plasma cytokine levels in necrotizing enterocolitis. Acta Paediatr 396:18-20, 1994 (suppl)
4. Ozdemir A, Oygur N, Gultekin M, et al: Neonatal tumor necrosis factor, interleukin-1 alpha, interleukin-1 beta, and interleukin-6 response to infection. Am J Perinatol 11:282-285, 1994
5. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869, 1985
6. Baumgartner JD, Glauser MP, McCutchan JA, et al: Prevention of gram-negative shock and death in surgical patients by prophylactic antibody to endotoxin core glycolipid. Lancet 2:59, 1985
7. Moore KW, Vieira P, Fiorentino DF, et al: Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein Barr virus gene BCRF1. Science 248:1230-1234, 1990
8. Marchant A, Deviere J, Byl B, et al: Interleukin-10 production during septicaemia. Lancet 343:707-708, 1994
9. Ishida H, Hastings R, Thompson-Snipes L, et al: Modified immunological status of anti-IL-10 treated mice. Cell Immunol 148:371-384, 1993
10. Howard M, Muchamuel T, Andrade S, et al: Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177:1205-1208, 1993
11. de Waal Malefyt R, Abrams JS, Bennett B, et al: Interleukin 10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209, 1991
12. Florentine DF, Zlotnik A, Mosmann TR, et al: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815, 1991
13. Niiro H, Otsuka T, Kuga S, et al: IL-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytes. Int Immunol 6:661-664, 1994
14. Cournoyer D, Caskey CT: Gene therapy of the immune system. Ann Rev Immunol 11:297, 1993
15. Moore KW, Roussel F, Banchereau J: Evolving principles in immunopathology: Interleukin 10 and its relationship to Epstein-Barr virus protein BCRF1. Springer Semin Immunopathol 13:157-166, 1991
16. Bett AJ, Prevec L, Graham FL: Packaging capacity of human adenovirus type 5 vectors. J Virol 67:5911, 1993
17. Shaked A, Csete M, Drazan K, et al: Adenovirus-mediated gene transfer in the transplant setting: II. Successful gene transfer to syngeneic liver grafts using adenoviral vectors. Transplantation 57:1508-1511, 1994
18. Drazan KE, Csete ME, Shen XD, et al: Hepatic function is preserved following efficient adenoviral gene transfer. J Surg Res 59:299-305, 1995
19. Smith TAG, Mehaffey MG, Kayda BD, et al: Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet 5:397-402, 1993
20. Stratakis CA, Mastorakos G, Chrousos GP: Interleukin-6 elevation in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr 125:504, 1994 (letter)
21. Drazan KE, Benhamou PY, Wu L, et al: Adenoviral transduction of liver allografts achieves regional levels of viral IL-10 which suppress alloreactivity in vitro. J Surg Res 59:219-223, 1995